Thermo Fisher Launches New AcroMetrix Coronavirus 2019 (COVID-19) RNA Control
Thermo Fisher Scientific Inc. (Waltham, MA, USA) has launched the AcroMetrix Coronavirus 2019 (COVID-19) RNA Control, its latest quality control product to monitor and validate COVID-19 molecular diagnostic tests. More...07 Apr 2020
New Coronavirus (COVID-19) Antibody Test Can Help Determine Past COVID Infection
Eurofins Scientific’s (Luxembourg) US clinical diagnostics network is offering blood-based antibody testing for Coronavirus SARS-CoV-2 that can identify people who were exposed, may have developed some level of immunity to COVID-19 but potentially had mild to no symptoms. Eurofins' network will initially run nearly 5,000 tests per day, or 200 results every hour, helping first responders and healthcare providers. More...07 Apr 2020
AI Algorithms for Analyzing Chest X-ray/CT Scan Aid in Treatment of COVID-19 Infected Patients
In an effort to help the medical community in the fight against COVID-19, VUNO (Seoul, South Korea), an AI medical imaging software company, is offering special versions of two AI products, VUNO Med- LungQuant and VUNO Med-Chest X-ray: COVID-19, encompassing both lung X-ray and CT modalities, respectively all at once. More...07 Apr 2020
Fluxergy Submits FDA EUA Request for One-Hour COVID-19 POC Test
Fluxergy LLC (Irvine, CA, USA), a research and medical diagnostic test company, has submitted an Emergency Use Authorization (EUA) request to the U.S. Food and Drug Administration (FDA) Center for Devices and Radiological Health, seeking an authorization that would permit medical professionals to begin using the company’s high-speed Research Use Only (RUO) test system as a COVID-19 diagnostic at the point-of-care (POC). More...06 Apr 2020
NEXTGENPCR Endpoint Thermocycler Decreases PCR Amplification Time for SARS-CoV-2 to Eight Minutes
Molecular Biology Systems, B.V. (Goes, The Netherlands), a biotechnology company, has developed a method using its NEXTGENPCR endpoint thermocycler and consumables that decreases PCR amplification time for SARS-CoV-2 to eight minutes. More...06 Apr 2020
ThermoGenesis Develops Blood Test to Detect COVID-19 in Minutes
ThermoGenesis Holdings, Inc. (Rancho Cordova, CA, USA), which provides automated cell processing tools and services in the cell and gene therapy field, has developed an advanced point-of-care test that will allow rapid diagnosis of the COVID-19 virus, including asymptomatic cases, using just a single drop of blood without the need for special lab equipment and deliver results in less than 10 minutes. More...06 Apr 2020
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Mobile Barrier
Tilted Mobile Leaded Barrier
New
Pneumatic Stool
Avante 5-Leg Pneumatic Stool
In Other News
Joerns Healthcare Doubles Production of COVID-19 Care Products
BIOTECON Expedites Launch of Viral RNA Extraction Kit for Detecting COVID-19
AI Algorithm-Based Test Can Speed Up COVID-19 Testing Eightfold and Locate Asymptomatic Carriers
Splitter Tubing Adapter Quadruples Ventilator Capacity
Cardiac Injury Predicts Mortality in COVID-19 Patients
Lung Ultrasound Identifies Patients with Coronavirus
Mount Sinai Developing `End-to-End` Diagnostics Solution for COVID-19
Vela Diagnostics to Offer Manual ViroKey SARS-CoV-2 RT-PCR Test
Cellink Relaunches Real-Time qPCR Instrument for COVID-19
Novacyt's Two-Hour Coronavirus Test Gains FDA Emergency Use Approval
Ortho Clinical Diagnostics Releases COVID-19 Antibody Test
Chembio Launches DPP COVID-19 Serological Point-of-Care Test
Amgen Partners with Adaptive Biotechnologies to Develop COVID-19 Treatments
A. Menarini and Credo Diagnostics Enter into Agreement for Distribution of SARS-CoV-2 Assay Kit
NeuMoDx Secures FDA Emergency Use Authorization for Coronavirus Test
World’s First Online Image-Based COVID-19 Diagnosis Improvement Tool Launched
Siemens Healthineers Announces Availability of Molecular Fast Track Diagnostics SARS-CoV-2 Assay Test Kit
DiaSorin’s COVID-19 Test Receives FDA Emergency Use Authorization
QIAGEN Receives US FDA EUA for First and Only Syndromic Coronavirus Test
Carolina Liquid Chemistries Offers COVID-19 Rapid Screen Antibody Test
Luminex Receives BARDA Contract to Support Development of Second, Rapid SARS-CoV-2 Test
Researchers Just Days Away from Testing Potential COVID-19 Vaccine on Humans
Beckman Coulter Developing Tests to Detect Coronavirus Antibodies
